Health Canada Approves Orkambi

As many of you may be aware, Health Canada granted approval to the new drug, Orkambi, in late January this year. In anticipation of the interest this is likely to generate among CF patients and their friends and family members, we have prepared a brief FAQ about Orkambi which you can access here. If you have any questions about this medication that are not addressed in the FAQ, please contact the clinic.


The St. Paul’s Hospital Adult Cystic Fibrosis Program is committed to improving the quality of life and health outcomes of individuals living with CF.

Read More